Delivery Order SPE2DB20D3303-SPE2DB25FA2GT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,871.55 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used to treat inflammatory...
- The Defense Logistics Agency awarded a $7,021.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML autoinjector on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing...
- The Defense Logistics Agency awarded a delivery order valued at $3,086.38 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on July 23, 2025, with an ultimate completion date of July 24, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used primarily to treat...
- The Defense Logistics Agency awarded a delivery order valued at $3,320.62 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on August 7, 2025, with ultimate completion by August 8, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ is a biologic medication used to treat autoimmune conditions, and this procurement represents a routine...
- The Defense Logistics Agency awarded a $5,392.46 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical supplies. This non-set-aside, firm fixed price delivery order was executed on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication used to treat autoimmune inflammatory...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of TALTZ 80 mg/ml auto-injector two-packs with a ceiling value of $8,391.13. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency (DLA) awarded a $9,973.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical product, with an ultimate completion date of July 30, 2025. This is a non-set-aside award issued on July 29, 2025, with fulfillment based at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a $31,833.56 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical products, with an ultimate completion date of July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $4,871.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on July 22, 2025, with completion scheduled for July 23, 2025. This non-set-aside competitive award will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat autoimmune inflammatory conditions, and the autoinjector formulation enables patient self-administration of...
- The Defense Logistics Agency awarded a delivery order valued at $21,929.06 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 MG/ML Autoinjector, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2GTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,383.13 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Syringe on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication commonly used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999.99 million and extending through December 2026. As the prime contractor on this IDC, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates its established capability to fulfill specialized medical procurement requirements through competitive federal contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/7/25 |